Micro Labs Limited — Citalopram Exporter Profile
Indian Pharmaceutical Exporter · #14 for Citalopram · $3.2M export value · DGFT Verified
Micro Labs Limited is the #14 Indian exporter of Citalopram with $3.2M in export value and 136 verified shipments. Micro Labs Limited holds a 1.3% market share in Citalopram exports across 10 countries. The company exports 76 pharmaceutical products worth $463.6M across 21 therapeutic categories.
Micro Labs Limited — Citalopram Export Profile: Buyers & Destinations
Where Does Micro Labs Limited Export Citalopram?
| Country | Value | Shipments | Share |
|---|---|---|---|
| BELGIUM | $1.2M | 46 | 37.3% |
| GERMANY | $554.9K | 24 | 16.8% |
| UNITED KINGDOM | $531.5K | 21 | 16.1% |
| NETHERLANDS | $411.8K | 19 | 12.5% |
| MEXICO | $239.3K | 9 | 7.3% |
| FRANCE | $155.3K | 14 | 4.7% |
| NIGERIA | $100.8K | 13 | 3.1% |
| THAILAND | $39.8K | 1 | 1.2% |
| PHILIPPINES | $33.7K | 2 | 1.0% |
| BAHRAIN | $0 | 4 | 0.0% |
Micro Labs Limited exports Citalopram to 10 countries. The largest destination is BELGIUM accounting for 37.3% of Micro Labs Limited's Citalopram shipments, followed by GERMANY (16.8%) and UNITED KINGDOM (16.1%). These destinations reflect Micro Labs Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Citalopram from Micro Labs Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MICRO LABS GMBH | GERMANY | $1.2M | 49 |
| MICRO LABS GMBH.. | BELGIUM | $352.4K | 15 |
| BROWN AND BURK UK LIMITED | UNITED KINGDOM | $342.5K | 16 |
| MSK PHARMALOGISTIC GMBH | GERMANY | $230.7K | 9 |
| MICRO LABS GMBH , | BELGIUM | $221.2K | 6 |
| BROWN AND BURK LIMITED | UNITED KINGDOM | $189.0K | 5 |
| MSK PHARMALOGISTIC GMBH. | GERMANY | $161.0K | 7 |
| CENTRE SPECIALITES PHARMACEUTIQUES | FRANCE | $155.3K | 14 |
| MICRO NOVA PHARMACEUTICALS IND | NIGERIA | $100.8K | 13 |
| COIMPORTEX SERVICIOS ADUANALES S.C. | MEXICO | $91.8K | 4 |
Micro Labs Limited supplies Citalopram to 18 buyers globally. The largest buyer is MICRO LABS GMBH (GERMANY), followed by MICRO LABS GMBH.. (BELGIUM) and BROWN AND BURK UK LIMITED (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Citalopram Export Value and How Much Does Micro Labs Limited Contribute?
India exported $148.8M worth of Citalopram through 7,372 shipments from 257 suppliers to 101 countries, serving 736 buyers globally. Micro Labs Limited contributes $3.2M to this total, accounting for 1.3% of India's Citalopram exports. Micro Labs Limited ships Citalopram to 10 countries through 18 buyers.
What Is the Average Shipment Value for Micro Labs Limited's Citalopram Exports?
Micro Labs Limited's average Citalopram shipment value is $23.4K per consignment, based on 136 shipments totaling $3.2M. The largest destination is BELGIUM (37.3% of Micro Labs Limited's Citalopram exports).
How Does Micro Labs Limited Compare to Other Indian Citalopram Exporters?
Micro Labs Limited ranks #14 among 257 Indian Citalopram exporters with a 1.3% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($28.0M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($23.0M), TORRENT PHARMACEUTICALS LTD ($17.3M). Micro Labs Limited processed 136 shipments to 10 destination countries.
What Citalopram Formulations Does Micro Labs Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ESCITALOPRAM MICRO LABS 10 MG FILMTABLET | $199.8K | 7 |
| ESCITALOPRAM MICRO LABS 10MG FILMTABLETT | $157.7K | 6 |
| ESCITALOPRAM 20mg FILM COATED TABLETS ( | $145.0K | 3 |
| ESCITALOPRAM 10MG FILM COATED TABLETS (I | $93.1K | 3 |
| ESCITALOPRAM MICRO LABS 10 MG FILMTABLETTEN (ESCITALOPRAM TABLETS 10 MG) 10X10 S, QTY-44180.000 FAC INV.706205127PCS | $83.6K | 3 |
| ESCITALOPRAM MICRO LABS 20 MG FILMTABLET | $70.2K | 4 |
| ESCITALOPRAM MICRO LABS 20 MG FILMTABLETTEN (ESCITALOPRAM TABLETS 20MG) PACK 10X10'S (TAX INV.NO.706205350) | $66.6K | 3 |
| ESCITALOPRAM MICRO LABS 20 MG FILMTABLETTEN (ESCITALOPRAM 20MG TABLETS) PACK 10X10'S TAX INV.NO.706205414 | $66.2K | 3 |
| ESCITALOPRAM MICRO LABS 20 MG FILMTABLETTEN PACK 10X10'S TAX INV.NO.706205413 | $66.1K | 3 |
| ESCITALOPRAM- MICRO LABS 5 MG FILMTABLET | $59.5K | 5 |
Micro Labs Limited exports 102 distinct Citalopram formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ESCITALOPRAM MICRO LABS 10 MG FILMTABLET with 7 shipments worth $199.8K.
Regulatory Requirements: Exporting Citalopram to Key Markets
What Micro Labs Limited must comply with to export Citalopram to its top destination countries
Germany — BfArM/EMA
Approval Process
Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.
Timeline: 12–18 months via Decentralized Procedure
GMP & Export Requirements
EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence
Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory
Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Micro Labs Limited Compare to Nearest Citalopram Exporters?
Exporters ranked immediately above and below #14 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | MEDISPRAY LABORATORIES PRIVATE LIMITED | $3.9M | 77 | 1 | $50.0K |
| 13 | GALPHA LABORATORIES LIMITED. | $3.8M | 92 | 1 | $41.8K |
| 14 | MICRO LABS LIMITED ★ | $3.2M | 136 | 10 | $23.4K |
| 15 | APOTEX RESEARCH PRIVATE LIMITED | $2.4M | 86 | 1 | $28.1K |
Micro Labs Limited ranks #14 among 257 Indian Citalopram exporters. Average shipment value of $23.4K compared to the market average of $579.1K. The closest competitors by value are MEDISPRAY LABORATORIES PRIVATE LIMITED and GALPHA LABORATORIES LIMITED..
Which Indian Ports Ship Citalopram Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 779 | 10.6% |
| SAHAR AIR | 684 | 9.3% |
| NHAVA SHEVA SEA (INNSA1) | 609 | 8.3% |
| HYDERABAD ICD | 593 | 8.0% |
| HYDERABAD ICD (INSNF6) | 411 | 5.6% |
| HYDERABAD AIR | 336 | 4.6% |
| DELHI AIR CARGO ACC (INDEL4) | 334 | 4.5% |
| DELHI AIR | 309 | 4.2% |
Geopolitical & Trade Policy Impact on Micro Labs Limited's Citalopram Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Micro Labs Limited. The Israel-Iran conflict has intensified tensions in the Red Sea, leading to increased shipping costs and potential delays. These disruptions can affect supply chain efficiency and profitability, necessitating strategic adjustments in logistics and distribution channels.
Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, creating an opportunity for Indian exporters to capture a larger market share. Micro Labs can leverage this shift by emphasizing its compliance with U.S. regulatory standards and ensuring a reliable supply chain.
The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on most European pharmaceutical exports to India. While this enhances market access for European manufacturers, it also intensifies competition for Indian exporters. Micro Labs must enhance its value proposition through innovation, cost efficiency, and adherence to EU regulatory standards to maintain its competitive edge. (en.wikipedia.org)
Micro Labs Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for pharmaceutical exporters. Micro Labs Limited has demonstrated a commitment to quality, as evidenced by its recognition as India’s Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company in 2024. This accolade reflects the company's adherence to stringent manufacturing practices and international guidelines. (einnews.com)
However, the evolving regulatory landscape, including the EU's Falsified Medicines Directive and the U.S. FDA's stringent quality requirements, necessitates continuous investment in compliance infrastructure. Micro Labs must proactively adapt to these changes to ensure uninterrupted market access and maintain its reputation for quality.
About Micro Labs Limited
Micro Labs Limited exports 76 products worth $463.6M. Beyond Citalopram, top products include Amoxicillin, Potassium, Gabapentin, Losartan, Esomeprazole. View the complete Micro Labs Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Citalopram — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Citalopram shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Micro Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 153 individual customs records matching Micro Labs Limited exporting Citalopram, covering 102 formulations to 10 countries via 18 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 101+ countries, 736+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Citalopram Export Data from Micro Labs Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Micro Labs Limited's Citalopram exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Micro Labs Limited
Full Company Profile →
76 products · $463.6M total trade · 21 categories
Citalopram Stats
Company Overview
Top Products by Micro Labs Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Micro Labs Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Citalopram. For current shipment-level data, contact TransData Nexus.